CJEU backs Warner-Lambert in marketing authorisation dispute

18-02-2019

CJEU backs Warner-Lambert in marketing authorisation dispute

nitpicker / Shutterstock.com

The Court of Justice of the European Union has issued a judgment in favour of Warner-Lambert amid a dispute between the American pharmaceutical company and an administrative body in the Netherlands.


Lyrica, generic drug, Court of Justice of the European Union, CJEU, generics, marketing authorisation, District Court of the Hague

LSIPR